Search

everythinglearnresearchcommunity

for

Search:↓

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

Balding men, especially young ones, may have higher risk of heart issues and diabetes; check cholesterol levels.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

The document suggests new ways to assess and diagnose hyperandrogenism to improve accuracy.

Hair loss can indicate brain aging and potential small vessel disease, but more research is needed to understand the clinical impact.

Hair loss linked to prostate enlargement; stress and family history important factors.

Lower SHBG levels may increase the risk of PCOS.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

Metabolic syndrome linked to female hair loss; waist size and high blood pressure important factors.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Female hair loss linked to metabolic syndrome, not in males.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.